COMBINED USE OF CAMPATH-1G IN-VIVO AND IN THE BAG IN ALLOGENEIC BONE-MARROW TRANSPLANTATION

Slični predmeti

• In vivo use of Campath-1G to prevent graft-versus-host disease and graft rejection after bone marrow transplantation.
  od: Willemze, R, i dr.
  Izdano: (1992)
• T cell depletion with CAMPATH-1 in allogeneic bone marrow transplantation.
  od: Hale, G, i dr.
  Izdano: (1988)
• Availability of Campath-1 antibodies for bone marrow transplantation.
  od: Hale, G, i dr.
  Izdano: (1995)
• CAMPATH-1 monoclonal antibodies in bone marrow transplantation.
  od: Hale, G, i dr.
  Izdano: (1994)
• Comparison of allogeneic T cell-depleted peripheral blood stem cell and bone marrow transplantation: effect of stem cell source on short- and long-term outcome.
  od: Barge, R, i dr.
  Izdano: (2001)